## **Core Concept**
The first-line treatment for tuberculosis (TB) in children, also known as Anti-Tubercular Therapy (ATT), typically involves a combination of antibiotics to effectively combat the disease and prevent the development of drug resistance. The World Health Organization (WHO) and other health authorities provide guidelines for the treatment of TB, which include recommendations for children.

## **Why the Correct Answer is Right**
The correct answer, , is the first-line ATT regimen recommended for children. This combination includes Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), and Ethambutol (E) for the intensive phase, typically given for 2 months, followed by a continuation phase with Isoniazid and Rifampicin for 4 months (2HRZE/4HR). This regimen is effective against drug-susceptible TB and is recommended by the WHO and other health organizations.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because it does not represent the standard first-line ATT regimen for children.
- **Option B:** - This option is incorrect as it lacks Ethambutol, which is part of the standard first-line regimen, and includes Streptomycin, which is typically reserved for specific cases due to its potential for ototoxicity and nephrotoxicity.
- **Option D:** - This option is incorrect because it does not accurately represent the first-line ATT regimen for children.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the first-line treatment for TB in children is 2HRZE/4HR, which is a combination of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol for 2 months, followed by Isoniazid and Rifampicin for 4 months. Monitoring for potential side effects, such as hepatotoxicity, and ensuring adherence to the treatment regimen are crucial.

## **Correct Answer:** .